Literature DB >> 1683767

Pancreatic cancer cell DNA content correlates with long-term survival after pancreatoduodenectomy.

D C Allison1, K K Bose, R H Hruban, S Piantadosi, W C Dooley, J K Boitnott, J L Cameron.   

Abstract

The DNA content of 47 adenocarcinomas arising in the head of the pancreas from patients who had undergone successful pancreatoduodenectomy was measured. The DNA measurements of each tumor were made without knowledge of the clinical course by absorption cytometry performed on Feulgen-stained nuclei that had been disaggregated from pancreatic cancer tissue blocks. Forty-seven evaluable DNA distributions were obtained from specimens taken between 1975 and 1988. Of the 47 tumors, 19 (40%) were diploid and 28 (60%) were aneuploid cancers. The 19 patients with diploid cancers had a median survival time of 25 months. Median survival of the 28 patients with aneuploid cancers was 10.5 months. This difference was statistically significant (p = 0.003). A multivariate life table regression analysis demonstrated that the ploidy and proliferative index as determined by absorption cytometry were independent prognostic factors, as strong as or stronger than the number of positive nodes and tumor size. Thus cellular DNA content appears to be one of the most important predictors of survival in patients with adenocarcinoma of the head of the pancreas who have successfully undergone a pancreaticoduodenectomy.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1683767      PMCID: PMC1358487          DOI: 10.1097/00000658-199112000-00002

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  49 in total

1.  Statistical aspects of the analysis of data from retrospective studies of disease.

Authors:  N MANTEL; W HAENSZEL
Journal:  J Natl Cancer Inst       Date:  1959-04       Impact factor: 13.506

2.  Survival in 1001 patients with carcinoma of the pancreas.

Authors:  M M Connolly; P J Dawson; F Michelassi; A R Moossa; F Lowenstein
Journal:  Ann Surg       Date:  1987-09       Impact factor: 12.969

3.  Prospective controlled trial of transhepatic biliary endoprosthesis versus bypass surgery for incurable carcinoma of head of pancreas.

Authors:  P C Bornman; E P Harries-Jones; R Tobias; G Van Stiegmann; J Terblanche
Journal:  Lancet       Date:  1986-01-11       Impact factor: 79.321

4.  [Computer-assisted diagnosis of fine-needle biopsy of the pancreas using automated microscopic image analysis (comparison of the Feulgen reaction and hemalum-eosin staining in pancreatic cancer and fibrosis].

Authors:  R Schöbl; V Dimmer
Journal:  Arch Geschwulstforsch       Date:  1989

5.  Ultrasonically guided fine-needle aspiration biopsy in focal pancreatic lesions.

Authors:  M Taavitsainen; A Koivuniemi; S Bondestam; L Kivisaari; E Tierala
Journal:  Acta Radiol       Date:  1987 Sep-Oct       Impact factor: 1.990

6.  Endoscopic biliary endoprosthesis in the palliation of malignant obstruction of the distal common bile duct: a randomized trial.

Authors:  H A Shepherd; G Royle; A P Ross; A Diba; M Arthur; D Colin-Jones
Journal:  Br J Surg       Date:  1988-12       Impact factor: 6.939

7.  The relationship of flow cytometric DNA analysis and clinicopathology in small-intestinal carcinoids.

Authors:  K Tsushima; D M Nagorney; L H Weiland; M M Lieber
Journal:  Surgery       Date:  1989-03       Impact factor: 3.982

8.  A correction required for calculation of DNA ratios in flow cytometric analysis of ploidy.

Authors:  A L Givan; B K Shenton; T W Carr
Journal:  Cytometry       Date:  1988-05

9.  Adenocarcinoma of the pancreas: a statistical analysis of biliary bypass vs Whipple resection in good risk patients.

Authors:  T M Shapiro
Journal:  Ann Surg       Date:  1975-12       Impact factor: 12.969

10.  Flow cytometric determination of DNA ploidy level in nuclei isolated from paraffin-embedded tissue.

Authors:  B Schutte; M M Reynders; F T Bosman; G H Blijham
Journal:  Cytometry       Date:  1985-01
View more
  25 in total

1.  Periampullary adenocarcinoma: analysis of 5-year survivors.

Authors:  B Gudjonsson
Journal:  Ann Surg       Date:  1999-11       Impact factor: 12.969

2.  Significance of proliferative activity and DNA ploidy in pancreatic cancer and chronic pancreatitis.

Authors:  H Loertzer; R Hinze; J Knolle; F W Rath; A Schmassmann
Journal:  Int J Pancreatol       Date:  1999-10

3.  Implications of malignant-cell DNA content for treatment of patients with pancreatic cancer.

Authors:  A L Warshaw
Journal:  Ann Surg       Date:  1991-12       Impact factor: 12.969

Review 4.  Current management of pancreatic carcinoma.

Authors:  K D Lillemoe
Journal:  Ann Surg       Date:  1995-02       Impact factor: 12.969

5.  Pancreaticoduodenectomy. Does it have a role in the palliation of pancreatic cancer?

Authors:  K D Lillemoe; J L Cameron; C J Yeo; T A Sohn; A Nakeeb; P K Sauter; R H Hruban; R A Abrams; H A Pitt
Journal:  Ann Surg       Date:  1996-06       Impact factor: 12.969

6.  Pancreaticoduodenectomy for pancreatic adenocarcinoma: postoperative adjuvant chemoradiation improves survival. A prospective, single-institution experience.

Authors:  C J Yeo; R A Abrams; L B Grochow; T A Sohn; S E Ord; R H Hruban; M L Zahurak; W C Dooley; J Coleman; P K Sauter; H A Pitt; K D Lillemoe; J L Cameron
Journal:  Ann Surg       Date:  1997-05       Impact factor: 12.969

7.  Molecular diagnosis of exocrine pancreatic cancer using a percutaneous technique.

Authors:  D B Evans; M L Frazier; C Charnsangavej; R L Katz; L Larry; J L Abbruzzese
Journal:  Ann Surg Oncol       Date:  1996-05       Impact factor: 5.344

8.  Resected adenocarcinoma of the pancreas-616 patients: results, outcomes, and prognostic indicators.

Authors:  T A Sohn; C J Yeo; J L Cameron; L Koniaris; S Kaushal; R A Abrams; P K Sauter; J Coleman; R H Hruban; K D Lillemoe
Journal:  J Gastrointest Surg       Date:  2000 Nov-Dec       Impact factor: 3.452

9.  Pancreatic adenocarcinomas with DNA replication errors (RER+) are associated with wild-type K-ras and characteristic histopathology. Poor differentiation, a syncytial growth pattern, and pushing borders suggest RER+.

Authors:  M Goggins; G J Offerhaus; W Hilgers; C A Griffin; M Shekher; D Tang; T A Sohn; C J Yeo; S E Kern; R H Hruban
Journal:  Am J Pathol       Date:  1998-06       Impact factor: 4.307

10.  Nuclear DNA content as a prognostic predictor in carcinoma of the pancreas.

Authors:  T Yoshimura; T Manabe; H Suwa; T Imamura; Z Wang; G Ohshio; H Yamabe; M Matsumoto; K Ogasahara; H Takasan
Journal:  Int J Pancreatol       Date:  1993-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.